Snowball logo
logo
TG40

Oxurion NV

TG40 • F
€0.0002€0.00  (0%)
Estimate
P/E
0
EPS
0.1
Beta
0.066
About the company
Ticker
TG40
ISIN
BE0974487192
Country
Belgium
Sector (GICS)
Other
Oxurion NV, a biopharmaceutical company, develops medicines for vascular retinal disorder in Belgium. The company is developing ophthalmic treatments to preserve vision for patients geographic atrophy and wet age-related macular degeneration. The company was formerly known as ThromboGenics NV and changed its name to Oxurion NV in September 2018. Oxurion NV was founded in 1991 and is headquartered in Leuven, Belgium.

Frequently asked questions

What sector does Oxurion NV (TG40) operate in?

Oxurion NV belongs to the Other sector and operates in the Biotechnology industry.

What is Oxurion NV (TG40) current stock price?

As of the latest data, Oxurion NV stock price is €0.00, with a previous close of €0.00.

What is Oxurion NV (TG40) current market capitalization?

Oxurion NV market cap is approximately 46.40 thousand.

What is Oxurion NV (TG40) Earnings Per Share (EPS)?

The trailing EPS is €0.10.

What is Oxurion NV (TG40) Price-to-Earnings (P/E) ratio?

Oxurion NV current P/E ratio is 0.

Does Oxurion NV (TG40) pay dividends?

No. Oxurion NV does not pay a dividend.

What is Oxurion NV (TG40) beta (volatility) score?

Oxurion NV has a beta of 0.066, indicating lower volatility than the overall market.